Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 90

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 90
---
 lease term began January 1, 2022 and expires on March 31, 2025 and includes
an option to extend the lease term through March 2028. This office generally supports the certain marketing and administrative functions.
We notified our landlord that we will not renew this lease upon expiration of its initial term on March 31, 2025.

ITEM 3. LEGAL PROCEEDINGS

See Note 18 to our
consolidated financial statements included in this Annual Report for information on various legal proceedings, which is incorporated
into this Item by reference. Additionally, we have been in discussions with the federal government regarding past inspections at
NJOF. For information regarding these discussions see Part I, Item 1A. “Risk Factors – We have been in discussions
with the federal government regarding past FDA inspections of our 503B facility, and to the extent we are unable to demonstrate
compliance with cGMPs and other required regulations, the government could seek injunctive remedies, including through a consent
decree and temporary injunction, the effects of which could be costly to us and could result in adverse consequences to our
business.”

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY,
RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is listed on
The Nasdaq Stock Market LLC under the symbol “HROW” and the Notes are listed on The Nasdaq Stock Market LLC under the symbols
“HROWL” and “HROWM.”

 53 

Holders

As of February 28, 2025, there
were approximately 57 stockholders of record (excluding an indeterminable number of stockholders whose shares are held in street or “nominee”
name) of our common stock.

Dividends

We have not paid any dividends
on our common stock since our inception and do not expect to pay dividends on our common stock in the foreseeable future.

Purchase of Equity Securities

We did not purchase any of our
equity securities during the fourth quarter of 2024.

Recent Sales of Unregistered Securities 

None.

ITEM 6. [RESERVED]

 54 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and
analysis of our financial condition and